ABOUT

Welcome to our World of Good Health

Since its inception in the UK in 2006, Accord has grown to be a dynamic global pharmaceutical company developing, manufacturing and distributing pharmaceutical products for over 70 countries around the globe.  Accord is the commercial arm of lntas Pharmaceuticals, one of India’s top 10 pharmaceutical companies and a pioneering biopharmaceutical company operating in India since 1976.  Accord controls all aspects of the pharmaceutical value chain from lab scale development to API manufacturing, clinical trial capability and world class finished product manufacturing; ensuring quality, reliability and value.

Global Presence: From Europe to Asia Pacific

2006
Inception of
Accord UK

2010
MHRA Approval of
Injectable Facility SEZK

2013
ISO 14001:2004 &
OHSAS 18001:2007
Certificate

2016
Malaysia, Myanmar,
Australia

2007
New Cytotoxic API
Plant Commissioned

2011
MHRA Approval
Oral Facility at SEZ

2014
First Biosimilar
Launch

2008
First Accord
Brand Product
Launched in UK

2012
Secondary Packaging
Site Open
(Haverhill, Cambridge)

2015
Philippines, Singapore,
Hong Kong

Committed to Quality, Society & The Environment

At Accord, we consider quality the key to our success. In addition to our strict adherence to GMP, our broader commitment to Corporate and Social Responsibility is central to every aspect of our business and its impact on the environment, community, employees, healthcare practitioners and patients.  Every single stakeholder at Accord is committed to providing quality products and adhering to all internal and external policies and guidelines for safety, quality and ethics.  In recognition of our commitment to Environmental Protection and Occupational Health and Safety, Accord has been awarded the ISO 14001 and OHSAS 18001 certifications.

Accord’s manufacturing facilities have successfully passed audits from a wide range of International Regulatory Bodies, including:

Accord – The Evolution of Generics